The Effect of Low Molecular Weight Heparins on Placentation: A Rat Model Study
Abstract
Low molecular weight heparins (LMWHs) have been used for the treatment for recurrent pregnancy loss (RPL) for a long time. We aimed to investigate the efficacy of the LMWHs on angiogenesis and apoptosis during placentation. A total of twenty-four rats were randomly divided into three groups each containing 8 rats: normal saline; enoxaparine sodium 0.4 ml, and enoxaparine sodium 0.8 ml were given to the Group 1, 2 and 3, respectively. Normal saline and enoxaparine sodium 0.4 ml or 0.8 ml were given to the rats beginning on the day the pregnancy was detected and continued until the 15th day of the pregnancy. The tissues containing placental decidual zone were immunostained for vascular endothelial growth factor A (VEGF-A) and caspase 7. The decidual and placental VEGF-A and the decidual caspase 7 immunostaining scores of all of the groups were high, however, there were no statistically significant differences among the groups (p>0.05). On the other hand, the placental caspase 7 immunostaining scores of the normal saline group were significantly lower than those of the enoxaparine sodium 0.4 and the enoxaparine sodium 0.8 groups (p<0.05). LMWHs seem to have effects on placental angiogenesis and apoptosis.
Keywords
Low molecular weight heparin, Placenta, Angiogenesis, Apoptosis.
References
- [1] Bick R.L., Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative Group, Clin. Appl. Thromb. Hemost., 6 (3) (2000) 115-125.
- [2] Ford H. B., Schust D. J., Recurrent pregnancy loss: etiology, diagnosis, and therapy, Rev. Obstet. Gynecol., 2 (2) (2009) 76-83.
- [3] Greer I.A., Inherited thrombophilia and venous thromboembolism. Best Pract. Res. Clin. Obstet. Gynaecol., 17 (3) (2003) 413-425.
- [4] Robertson L., Wu O., Langhorne P., Twaddle S., Clark P., Lowe G.D.O., Walker I.D., Greaves M., Brenkel I., Regan L., Greer I. A., for TheThrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study, Thrombophilia in pregnancy: a systematic review, Br. J. Haematol., 132 (2) (2006) 171-196.
- [5] Blumenfeld Z., Brenner B., Thrombophilia-associated pregnancy wastage, Fertil. Steril., 72 (5) (1999) 765-774.
- [6] Ingman K., Cookson V.J.K.W., Jones C.J.P., Aplin J.D., Characterisation of hofbauer cells in first and second trimester placenta: incidence, phenotype, survival in vitro and motility, Placenta, 31 (6) (2010) 535-544.
- [7] Poole, T.J., Coffin, J. D., Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern, J. Exp. Zool., 251 (2) (1989) 224-231.
- [8] Speroff L., Fritz M.A., In: Taylor, H.S. (Ed). Klinik Jinekolojik Endokrinoloji ve İnfertilite. 7th ed. İstanbul: Güneş Kitabevi (2007).
- [9] Toder V., Carp H., Fein A. Torchinsky A., The role of pro- and antiapoptotic molecular interactions in embryonic maldevelopment, Am J Reprod Immunol., 48 (4) (2002) 235-244.
- [10] Pierangeli S.S., Pojen P.C., Raschi E., Scurati S., Grossi C., Borghi M.O., Palomo I., Harris E.N., Meroni P.L., Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms, Semin. Thromb. Hemost,, 34 (3) (2008) 236-250.